RRML - Identification of shared hub genes in lung cancer and rheumatoid arthritis patients using bioinformatics approaches
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- April 2024 -
 
A comprehensive review of Prof... 25
Recomandarea comună EFLM-COLA... 15
Anti-thyroid peroxidase (TPO) ... 11
Understanding the key differen... 10
Monocyte to high-density lipop... 10
Romanian Review of Laboratory ... 7
Approaching Risk Management in... 7
Understanding the pathogenesis... 7
Predictive value of expression... 7
Function of the S1P pathway in... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 32(1)/2024 DOI:10.2478/rrlm-2024-0007
XML
TXT

Research article

Identification of shared hub genes in lung cancer and rheumatoid arthritis patients using bioinformatics approaches

ChangMao Deng, ChangHong Wei, ZiChen Shao, Ling Cheng, QinQin Deng, Wei Xiong, Xinju Hou

Correspondence should be addressed to: ZiChen Shao, Ling Cheng, Xinju Hou

Abstract:

Objectives:To identify key genes common to lung cancer and rheumatoid arthritis through WGCNA co-expression network and MCC algorithm analysis. Methods: Initially, chip data related to lung cancer and rheumatoid arthritis were obtained from the GEO database for data integration and differential analysis, leading to the identification of key differentially expressed genes. Subsequently, WGCNA was utilized to construct a co-expression network, identifying susceptible modules and core genes. Further, common core genes in lung cancer and rheumatoid arthritis were identified through Venn diagrams, assessing their diagnostic accuracy in disease, analyzing differential expression, and constructing a co-expression network. Finally, GO and KEGG enrichment analyses were conducted to understand the functions and pathway enrichment of these core genes, and potential target drugs were predicted. Results: Six lung cancer-related and three rheumatoid arthritis-related gene co-expression modules were constructed using WGCNA. The Turquoise module was identified as the susceptible module for lung cancer, while the Blue module was for rheumatoid arthritis. A total of 953 genes were included in the lung cancer hub genes, and 152 in the rheumatoid arthritis hub genes. Finally, 92 potential target drugs were predicted through the DGIdb database that may regulate the expression of 11 common hub genes. Conclusion: We identified 24 common hub genes for lung cancer and rheumatoid arthritis, with the top 6 ranked by the MCC algorithm being FGR, SLA, GZMH, CSF2RB, PRF1, and CCRL2. This study paves the way for further exploration of the common pathogenesis of lung cancer and rheumatoid arthritis. However, further in vivo and in vitro experiments are required for validation and support.

Keywords: WGCNA co-expression network, lung cancer, rheumatoid arthritis, key genes, bioinformatics

Received: 29.11.2023
Accepted: 15.1.2024
Published: 21.1.2024

 
  PDF Download full text PDF
(7799 KB)
     
 
How to cite
Deng C, Wei C, Shao Z, Cheng L, Deng Q, Xiong W, et al. Identification of shared hub genes in lung cancer and rheumatoid arthritis patients using bioinformatics approaches. Rev Romana Med Lab. 2024;32(1):41-54. DOI:10.2478/rrlm-2024-0007